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Chronic exposure to inorganic arsenic (iAs) 
through elevated concentrations in drink-
ing water is a major environmental health 
hazard throughout the world, particularly in 
Bangladesh and India, resulting in increased 
risk of cancer and numerous noncancer 
effects (International Agency for Research on 
Cancer 2004). iAs is readily transferred to the 
fetus (Concha et al. 1998), and recent studies 
have shown increased rates of fetal loss, pre-
term births, and neonatal mortality (Ahmad 
et al. 2001; Milton et al. 2005; Rahman 
et al. 2007), as well as decreased birth weight 
(Hopenhayn et al. 2003; Rahman et al. 
2009), at fairly low exposure levels. The 
mechanisms of arsenic (As)-induced develop-
mental toxicity are, however, poorly under-
stood (Vahter 2009).
One of the mechanisms of As toxicity is 
generation of reactive oxygen species, possi-
bly in combination with impaired antioxida-
tive defense (Vahter 2009; Wu et al. 2001). 
Our ongoing, prospective, mother–child 
cohort study in rural Bangladesh has shown 
that women in early gestation have As-related 
increases in urinary 8-oxo-7, 8-dihydro-2´-
deoxyguanosine (8-OHdG), a product of oxi-
dative DNA damage that is used as a marker 
of oxidative stress (Engstrom et al. 2010). 
Oxidative stress in the placenta may trigger 
secretion of proinflammatory factors and has 
been associated with preeclampsia (Cindrova-
Davies et al. 2007; Myatt 2006).
As has also been shown to induce immu-
nosuppression in epidemiological and experi-
mental studies. Our ongoing studies in 
Bangladesh showed that exposure to As dur-
ing pregnancy was associated with decreased 
thymic size in the children and increased 
infectious diseases in both mothers and chil-
dren, indicating As-related immunosuppres-
sion (Moore et al. 2009; Rahman et al. 2010; 
Raqib et al. 2009). In vitro and in vivo studies 
have shown reduced lymphocyte prolifera-
tion, reduced CD4+ cell counts, CD4+:CD8+ 
cell ratios, and reduced T-regulatory cells 
in exposed adults and children (Biswas 
et al. 2008; Hernandez-Castro et al. 2009; 
Soto-Pena et al. 2006). Experimental stud-
ies in mice have also shown dose-dependent 
increases in apoptosis of thymocytes and sple-
nocytes (Stepnik et al. 2005) and decreased 
bacterial clearance from the blood and spleen 
after chronic As exposure (Bishayi and 
Sengupta 2003). In this study, we aimed to 
increase our understanding of the impact of 
As exposure during pregnancy on immune 
function in terms of immune and inflamma-
tory markers in the placenta and cord blood 
in association with oxidative stress.
Materials and Methods
Study area and subjects. The study area, 
Matlab, is located 53 km southeast of Dhaka, 
Bangladesh. The International Centre for 
Diarrhoeal Disease Research, Bangladesh, 
runs a health and demographic surveillance 
system (HDSS) in Matlab, as well as a cen-
tral hospital and four connected subcenters 
that provide health care to the resident popu-
lation in the areas. About 70% of the tube 
wells in Matlab exceed the World Health 
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Ba c k g r o u n d: Arsenic (As) exposure during pregnancy induces oxidative stress and increases the 
risk of fetal loss and low birth weight.
oBjectives: In this study we aimed to elucidate the effects of As exposure on immune markers in 
the placenta and cord blood, and the involvement of oxidative stress.
Me t h o d s : Pregnant women were enrolled around gestational week (GW) 8 in our longitudinal, 
population-based, mother–child cohort in Matlab, an area in rural Bangladesh with large variations 
in As concentrations in well water. Women (n = 130) delivering at local clinics were included in the 
present study. We collected maternal urine twice during pregnancy (GW8 and GW30) for measure-
ments of As, and placenta and cord blood at delivery for assessment of immune and inflammatory 
markers. Placental markers were measured by immunohistochemistry, and cord blood cytokines by 
multiplex cytokine assay.
re s u l t s: In multivariable adjusted models, maternal urinary As (U-As) exposure both at GW8 and 
at GW30 was significantly positively associated with placental markers of 8-oxoguanine (8-oxoG) 
and interleukin-1β (IL-1β); U-As at GW8, with tumor necrosis factor-α (TNFα) and interferon-γ 
(IFNγ); and U-As at GW30, with leptin; U-As at GW8 was inversely associated with CD3+ T cells 
in the placenta. Cord blood cytokines (IL-1β, IL-8, IFNγ, TNFα) showed a U-shaped association 
with U-As at GW30. Placental 8-oxoG was significantly positively associated with placental proin-
flammatory cytokines. Multivariable adjusted analyses suggested that enhanced placental cytokine 
expression (TNFα and IFNγ) was primarily influenced by oxidative stress, whereas leptin expres-
sion appeared to be mostly mediated by As, and IL-1β appeared to be influenced by both oxidative 
stress and As.
co n c l u s i o n: As exposure during pregnancy appeared to enhance placental inflammatory responses 
(in part by increasing oxidative stress), reduce placental T cells, and alter cord blood cytokines. 
These findings suggest that effects of As on immune function may contribute to impaired fetal and 
infant health.
key w o r d s : arsenic, cytokines, 8-oxoguanine, leptin, oxidative stress, placenta. Environ Health 
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Organization guideline level of As in drinking 
water of 10 µg/L, and 50% exceed the national 
standard of 50 µg/L (Rahman et al. 2006).
This study is nested in a large, randomized, 
population-based food and multimicronutrient 
supplementation trial [Maternal and Infant 
Nutrition Interventions, Matlab (MINIMat) 
trial; ISRCTN16581394], which evaluated 
nutritional and environmental impacts on 
pregnancy outcomes and child health (Moore 
et al. 2009; Raqib et al. 2009; Tofail et al. 
2008). Pregnancy was identified by urine test 
in women (n = 3,600) who reported missing 
a menstrual period at monthly home visits by 
HDSS workers. Once pregnancy was identi-
fied, usually during gestational weeks (GW) 
6–10 (mean, GW8), women were advised to 
visit a health facility in their area for confirma-
tion of pregnancy by ultrasound and for ante-
natal care. Women were then invited to enroll 
into the MINIMat trial and were requested to 
donate urine samples at enrollment (GW8) 
and at GW30 and cord blood and placenta at 
delivery. In the MINIMat trial, women were 
randomized to receive one of three different 
combinations of micronutrient supplements, 
daily from GW14 up to birth: a) 30 mg iron 
plus 400 µg folic acid, b) 60 mg iron plus 
400 µg folic acid, and c) the UNICEF prepa-
ration of 15 different micronutrients including 
30 mg iron and 400 µg folic acid. Participants 
gave written, informed consent, and the study 
was approved by the ethical review commit-
tee of International Centre for Diarrhoeal 
Disease Research, Bangladesh. The women 
could not be informed about their As status 
during their pregnancy because these analyses 
were done later.
Field research assistants collected morbid-
ity information, based on a set of structured 
questionnaires, from pregnant women dur-
ing the scheduled monthly home visits. The 
questionnaires included four specific morbid-
ity questions concerning diarrhea/dysentery, 
respiratory illness (in terms of cold, cough, or 
difficult breathing), and urinary tract infec-
tions (in terms of pain/burning/difficulty dur-
ing urination) with or without concomitant 
fever, including the duration of the morbidity 
symptoms (days of illness). Socioeconomic 
status (SES) was based on family assets using 
data from the HDSS database (Raqib et al. 
2009; Tofail et al. 2008).
The present cohort consists of a con-
venience sample of 130 women delivering 
singleton infants at the central Matlab hos-
pital or any of the four connected subcenters 
during early daytime (0500 to 1430 hours). 
Home deliveries and later deliveries could 
not be included because of logistic difficulties 
of processing and transferring samples to the 
Dhaka laboratory. Birth weight was measured 
within 72 hr of delivery using electronic scales 
(Seca pediatric scales; Seca GmbH, Hamburg, 
Germany) with precision of 10 g. The infant’s 
length was measured using a validated, locally 
manufactured wooden length board, with 
precision of 0.1 cm.
As exposure. The concentration of metabo-
lites of iAs in urine was used as a biomarker of 
exposure because it reflects the ingested dose 
of iAs from all sources (Vahter et al. 2006). 
Although the half-life of iAs in the body is 
relatively short, the daily exposure through 
water and food results in fairly stable steady-
state concentrations in urine. In the larger 
MINIMat cohort, we observed that maternal 
urinary As (U-As) is tightly correlated with 
blood As levels (r2 = 0.83, p < 0.001; unpub-
lished data). As in hair and nail samples, used 
sometimes as biomarkers of As exposure over 
several months, were not considered in this 
highly exposed population because of risk of 
external exposure contamination, for exam-
ple, bathing and washing in contaminated 
water. Because As easily crosses the placenta 
(Concha et al. 1998), the concentration in 
maternal urine during pregnancy was used as 
a proxy marker of fetal exposure.
Urine was collected into trace element–
free plastic cups, transferred to 24-mL poly-
ethylene bottles, and stored at –70°C in the 
laboratory. The mothers’ U-As, defined as 
the sum of iAs and iAs metabolites in urine 
(iAs + methylarsonic acid + dimethylarsinic 
acid), was determined using hydride genera-
tion atomic absorption spectrophotometry 
(Vahter et al. 2006). The limit of detection 
(LOD) was 1.3 ± 0.27 µg/L. To compen-
sate for variation in dilution, urine samples 
were adjusted for specific gravity measured 
by a digital refractometer (RD712 Clinical 
Refractometer; EUROMEX, Arnhem, 
Holland). Adjustment by specific gravity has 
been shown to be less affected by body size, 
SES, and As exposure than the more com-
monly used creatinine adjustment (Nermell 
et al. 2008).
Processing of placental tissue for immu-
nostaining. Placental tissue was collected 
from mothers immediately after delivery at 
the clinic. A 2 × 2-inch piece from the fetal 
portion of the placenta was cut and immersed 
in 10% buffered formalin (pH 7.0) kept at 
room temperature (RT). Smaller pieces were 
cut from the placental specimen and divided 
into two sets. One set was fixed, embed-
ded in paraffin, sectioned by Microtome 
(Leica, Nussloch, Germany) at 3-mm thick-
ness, mounted on glass slides treated with 
Vectabond reagent (Vector Laboratories, 
Burlingame,CA, USA), dried overnight at 
37°C, and kept at RT before use for immu-
nostaining. The second set of tissues was 
immersed in 15% sucrose buffer overnight 
and, after removal of excess fluid, was snap-
frozen in liquid nitrogen to retain the anti-
genic properties.
Immunohistochemical detection of 
cell surface markers and proinflammatory 
  cytokines. Paraffin-embedded tissue sections 
were deparaffinized and microwave-treated 
in target retrieval solution (pH 6.0–6.2) for 
antigen retrieval. After blocking endo  genous 
peroxidase activity and nonspecific staining, 
the slides were incubated sequentially with pri-
mary antibodies (overnight at RT), antibody 
conjugate, and avidin-biotin complex at 37°C 
for 30 min, each with inter  mittent washing. 
Positive staining was developed with sub-
strate 3,3´-diaminobenzidine (Sigma-Aldrich, 
St. Louis, MO, USA). Sections were coun-
terstained with hematoxylin, dehydrated, and 
mounted. Frozen tissue blocks were sectioned 
with a cryo  microtome (Leica) at 4–5 µm thick-
ness. Staining for CD64 and cytokines was 
performed in the cryostat sections as described 
previously (Raqib et al. 1995). Primary anti-
bodies used were anti-human: CD3 (pan T 
cell), CD8 (cytotoxic/  suppressor T cells), CD64 
(FcgRI, monocytes/  macrophages), CD68 
(phagocytes), myeloperoxidase (MPO; neutro-
phils), interleukin-1β (IL-1β), and iterferon-γ 
(IFNγ) (all above from DakoCytomation, 
Glostrup, Denmark); leptin ob (Y-20) (Santa 
Cruz Biotechnology, Inc., Santa Cruz, CA, 
USA); tumor necrosis factor-α (TNFα) (BD 
Biosciences, Sparks, MD, USA); IL-6 (BD 
Pharmingen, San Diego, CA, USA); IL-10 
(Mabtech, Cincinnati, OH, USA); and 8-oxo-
guanine (8-oxoG) (Chemicon International, 
Temecula, CA, USA).
Image analysis of immunostaining. 
Immunohistochemical staining of specific 
markers in the placental specimens was ana-
lyzed with a microscope (Olympus BX51; 
Olympus Optical Co. Ltd., Tokyo, Japan) 
connected to a CCD camera (DCF295; 
Leica Microsystems CMS GmbH, Wetzlar, 
Germany) and the image analysis system Leica 
Qwin Runner (version 3). Special software 
(Tissue-includer), written in the high-level 
language QUIPS, was used to examine each 
video microscopic digital image. The color 
and morphology of the hematoxylin counter-
stained cells were set as a standard for positive 
and negative cells, and the positive staining 
of markers in placental tissue sections was 
defined by Leica software (Sarker et al. 2009). 
The acquired video microscopic image was 
divided into 512 × 512 pixels, and each pixel 
was expressed in square micrometers (area) 
after calibration with the current magnifica-
tion. For each placental tissue section, all fields 
(average, 400 ± 25 fields) were investigated at 
400× magnification, and the average of all 
fields was used for quantification of immunos-
taining in each tissue section. The results were 
expressed as {(total positively stained area) × 
(total mean intensity [1–256 levels per pixel] 
of the positive area)} / total cell area, in units 
referred to as acquired computerized image Ahmed et al.
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analysis (ACIA) scores [see Supplemental 
Material, “Computerized Image Analysis 
for  Detection  of  Immunostaining,” 
and Supplemental Material, Figure 1 
(doi:10.1289/ehp.1002086)].
For T-cell (CD3+, CD8+) staining, the 
computerized image analysis technique could 
not be applied because the numbers of cells 
in the total tissue section were very small, so 
ACIA scores were very low. T-cell phenotypes 
in the placental sections were assessed manu-
ally using an ocular micrometer fitted into the 
eyepiece of the microscope (Olympus Optical 
Co. Ltd.), and data were calculated as number 
of cells per 100-µm2 field area. Two trained 
individuals counted 400 fields separately, and 
the average was used.
Cytokines assay in cord blood plasma. 
Cord blood specimens were collected in hep-
arin-coated sterile vials (Becton Dickinson, 
Rutherford, NJ, USA) at the subcenter health 
clinics at delivery and were transported on ice 
to the laboratory. Plasma was separated and 
stored at –70°C until analyzed by Bio-Plex 200 
reader (BioRad Laboratories, Hercules, CA, 
USA). Cytokine levels in plasma were deter-
mined using Bio-Plex Pro Human Cytokine 
18-Plex Panel [IL-1β, IL-2, IL-4, IL-5, Il-6, 
IL-7, IL-8, IL-10, IL-12 (p70), IL-13, IL-17, 
granulocyte colony-stimulating factor, gran-
ulocyte-macrophage colony-stimulating fac-
tor, IFNγ, monocyte chemotactic protein-1, 
macrophage inflammatory protein-1β, TNFα, 
and human interferon-inducible protein-10] 
according to the manufacturer’s instructions. 
The LOD was approximately 10 pg/mL for 
these cytokines. For cytokine measurements 
with values below LOD, the LOD divided by 
square root of 2 was used.
Statistical analysis. Statistical analyses were 
performed using the software PASW 18.0 
(SPSS Inc., Chicago, IL, USA). Data distri-
bution pattern (normality) and homogeneity 
of variances were checked. Concentrations 
and ACIA score data were log transformed if 
not normally distributed. Covariates [mater-
nal age, morbidity, body mass index (BMI), 
gestational age, parity, SES, tobacco chewing 
(TC), birth weight, supplementation group, 
sex of the children] were evaluated for signifi-
cant association with exposure and outcomes. 
Spearman’s correlation was used to evaluate 
univariate associations between covariates and 
U-As (GW8 and GW30) and immune and 
inflammatory markers in cord blood and pla-
centa. Significantly correlated variables were 
further analyzed in multivariable adjusted 
regression models controlling for potential 
confounders. Potential confounders were 
identified based on correlations (p < 0.15) 
with the exposure (As) and outcome and were 
included in final models when they changed 
the effect estimate for U-As on the outcome 
by 5% or more. Mothers’ age, SES, and TC 
were included in the final model. Cord blood 
cytokines were analyzed according to quartiles 
of As exposure (n = 130; i.e., 32–33 in each 
quartile). Analysis of covariance (ANCOVA) 
was done to analyze the association of As 
Table 1. Demographic data of the study group of 
130 mother–child pairs.
Characteristic Value
Pregnant women
Age of women at enrollment (years)
Mean ± SD 25.5 ± 5.9
Median (10th–90th percentiles) 24 (17–36)
BMI at GW8 (kg/m2)
Mean ± SD 20.6 ± 2.9
Median (10th–90th percentiles) 19.86 (17.08–24.60)
BMI at GW30 (kg/m2)
Mean ± SD 23.0 ± 2.6
Median (10th–90th percentiles) 22.37 (19.83–26.52)
Gestational age (weeks)
Mean ± SD 39.5 ± 1.5
Median (10th–90th percentiles) 39 (37–41)
Supplementation groupa
1 43 (33%)
2 42 (32%)
3 45 (35%)
Parity
0 55 (42%)
1–2 54 (42%)
3–7 21 (16%)
Socioeconomic status
Low 38 (29%)
Middle 26 (20%)
High 66 (51%)
U-As at GW8 (µg/L)b
Median (10th–90th percentiles) 66 (23–343)
Mean ± SD 136 ± 167
U-As at GW30 (µg/L)b
Median (10th–90th percentiles) 60 (20–374)
Mean ± SD 143 ± 164
Tobacco chewing
Yes 29 (22%)
No 101 (78%)
Children
Birth weight (g)
Mean ± SD 2,786 ± 385
Median (10th–90th percentiles) 3,794 (2,353–3,300)
Low birth weight (< 2,500 g) 20 (16.0%)
Birth length (cm)
Mean ± SD 47.0 ± 1.9
Median (10th–90th percentiles) 48 (45–50)
Girls 62 (48.0%)
Values shown are n (%) unless otherwise noted.
aSupplementation groups: 1, 30 mg iron plus 400 µg folic 
acid; 2, 60 mg iron plus 400 µg folic acid; 3, the UNICEF 
preparation of 15 different micronutrients including 30 
mg iron and 400 µg folic acid. bAdjusted to average spe-
cific gravity of 1.012 g/mL. 
Table 2. Multivariable adjusted analysis of associations of maternal U-As (µg/L) in early and late preg-
nancy with placental effect markers, for CD3+ and CD8+ cells (cells/100 µm2 field area) and for other cells 
and cytokines (ACIA score).
Independent variable
Unadjusted Adjusteda
Dependent variable U-As at GW8 U-As at GW30 U-As at GW8 U-As at GW30
CD3
β-Coefficient –0.64 –0.44 –0.66 –0.46
95% CI –1.07 to –0.20 –0.90 to 0.03 –1.19 to –0.12 –1.04 to 0.12
p-Value 0.004 0.066 0.017 0.11
CD8
β-Coefficient –0.20 –0.08 –0.20 0.07
95% CI –0.55 to 0.15 –0.45 to 0.30 –0.66 to 0.25 –0.56 to 0.41
p-Value 0.26 0.68 0.37 0.76
CD64
β-Coefficient –0.29 –0.18 –0.28 –0.18
95% CI –0.57 to –0.01 –0.49 to 0.12 –0.68 to 0.10 –0.61 to 0.23
p-Value 0.04 0.24 0.14 0.37
8-oxoG
β-Coefficient 0.78 1.08 0.79 1.07
95% CI 0.40 to 1.16 0.71 to 1.45 0.32 to 1.26 0.60 to 1.54
p-Value < 0.001 < 0.001 0.001 < 0.001
IL-1β
β-Coefficient 0.71 0.92 0.70 0.93
95% CI 0.21 to 1.20 0.43 to 1.41 0.02 to 1.38 0.25 to 1.61
p-Value 0.006 < 0.001 0.043 0.009
TNFα
β-Coefficient 0.78 0.53 0.75 0.51
95% CI 0.37 to 1.19 0.07 to 1.02 0.14 to 1.36 –0.17 to 1.20
p-Value < 0.001 0.025 0.017 0.13
IFNγ
β-Coefficient 0.64 0.58 0.62 0.55
95% CI 0.21 to 1.06 0.11 to 1.04 –0.01 to 1.26 –0.13 to 1.24
p-Value 0.004 0.015 0.05 0.11
Leptin
β-Coefficient 0.04 0.31 0.04 0.31
95% CI –0.09 to 0.17 0.18 to 0.43 –0.12 to 0.20 0.15 to 0.47
p-Value 0.57 < 0.001 0.61 < 0.001
CI, confidence interval. Outcomes and exposure variables were natural log transformed. 
aAdjusted for mother age, SES, and TC.Arsenic-induced inflammation in placenta
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and cord blood cytokines by adjusting for 
the same confounding factors as above if the 
association was significant in one-way analysis 
of variance (ANOVA). p-Values < 0.05 were 
considered significant.
Results
Demographic data and As exposure. The 
average age of the pregnant women was 
25.5 years, and the average gestation age at 
delivery was 39.5 weeks, with small varia-
tions (Table 1). Of the 130 births, 68 were 
male and 62 were female. Twenty infants 
(8 males and 12 females) were of low birth 
weight (< 2,500 g). The range of parity was 
0 to 7. All women were nonsmokers; how-
ever, 22% of the women reported TC. The 
“chewing tobacco” consists of dried tobacco 
leaves locally known as zarda (sweetened 
tobacco leaves) or gul (dried and powdered 
tobacco). Zarda is taken in a mixture of sliced 
areca nut, lime, and a leaf of the piper betel 
plant, whereas gul is placed between the gums 
to be slowly sucked (Lindberg et al. 2010).
The median U-As concentrations at GW8 
and GW30 were similar at 66 and 60 µg/L, 
respectively. However, we observed consider-
able interindividual variation in As exposure. 
Although U-As in GW8 and GW30 were 
significantly correlated (r = 0.599, p < 0.001), 
15 women showed decreasing concentrations 
by > 50 µg/L, whereas 20 women showed 
increasing concentrations by > 50 µg/L from 
early to late gestation. Therefore, we evaluated 
the outcomes by maternal U-As in early and 
late gestation separately.
Maternal As exposure and placental 
immune markers. Localization of the various 
markers in the placenta was generally same 
for all subjects. We generally found increased 
expression of the various cytokines and 
reduced cell counts/expression at high expo-
sure levels [median U-As > 60 µg/L at GW30; 
see Supplemental Material, Figure 2 and 
“Localization of immune cells and inflamma-
tory markers in the placenta” (doi:10.1289/
ehp.1002086)].
Maternal As exposure and placental 
immune cells. Evaluation of associations 
between As exposure during pregnancy (U-As 
at GW8 and GW30) and the phenotypic 
expression of immune cells in the placenta 
(CD3+, CD8+, CD64+, CD68+, MPO) by 
regression analysis showed a significant nega-
tive association between CD3+ cell frequency 
in the placenta and U-As at GW8 but not 
at GW30 (Table 2, Figure 1A,B). The asso-
ciation remained significant after adjusting 
for age, SES, and TC (Table 2). Placental 
CD8+ cells decreased with increasing U-As 
at GW8, but the trend was not significant 
(Table 2, Figure 1A). The CD64+ cells 
were significantly negatively associated with 
U-As at GW8 but not at GW30 (Table 2, 
Figure 1C,D). We found no significant asso-
ciation between maternal U-As at GW8 or 
GW30 and placental expression of CD68 
(phagocytes) and MPO [neutrophils; see 
Supplemental Material, Table 1 (doi:10.1289/
ehp.1002086)]. We found no significant 
effect of micronutrient supplementation on 
placental or cord blood outcome variables and 
no difference in As exposure among supple-
mentation groups. We found no significant 
association between the sex of the infant and 
placental and cord blood immune parameters 
or As exposure.
Maternal As exposure and cytokines and 
oxidative damage in placenta. In regres-
sion analyses (Table 2), we found signifi-
cant positive associations between U-As at 
both GW8 and GW30 and the placental 
expression of 8-oxoG (Figure 1E,F), IL-1β, 
TNFα, and IFNγ (Figure 1G,H). Placental 
expression of leptin was significantly asso-
ciated with U-As at GW30 but not at 
GW8 (Figure 1E,F). We found no signifi-
cant associations between IL-6 or IL-10 and 
U-As [see Supplemental Material, Table 1 
(doi:10.1289/ehp.1002086)]. In multivariable 
Figure 1. (A and B) Association between U-As and frequencies of placental CD3+ and CD8+ cells, using 
quartiles of U-As concentrations at GW8 (A; n = 130, 32–33 in each quartile; median U-As, 26, 46, 115, and 
341 µg/L, respectively) and GW30 (B; n = 130, 32–33 in each quartile; median U-As, 27, 48, 121, and 335 µg/L, 
respectively). (C and D) Association between U-As and expression of CD64+ and CD68+ cells, using 
quartiles of U-As exposure at GW8 (C) and GW30 (D). (E and F) Association between U-As and 8-oxoG 
and leptin expression, using quartiles of U-As exposure at GW8 (E) and GW30 (F). (G and H) Association 
between U-As and TNFα, IFNγ, and IL-1β expression, using quartiles of U-As concentrations at GW8 (G) 
and GW30 (H). Data are means ± SE. Ln, natural log. 
*p < 0.05 for U-As modeled as a continuous variable in multivariable-adjusted linear regression analysis (Table 2). 
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adjusted linear regressions analysis (adjusting 
for age, SES, and TC), U-As at both GW8 
and GW30 was significantly associated with 
placental 8-oxoG and IL-1β; U-As at GW8, 
with TNFα and IFNγ; and U-As at GW30, 
with leptin (Table 2).
Placental 8-oxoG was significantly asso-
ciated with several placental cytokines (lep-
tin, IL-1β, TNFα, and IFNγ) (Table 3). To 
investigate whether the estimated effects of 
As on placental cytokines may have been 
mediated via oxidative stress, we performed 
multivariable adjusted linear regression with 
placental cytokines (leptin, IL-1β, TNFα, 
and IFNγ) as dependent variables and U-As as 
independent variable, controlling for 8-oxoG 
and potential confounders (Table 3). All the 
associations between placental cytokines and 
U-As at GW8 did not remain significant 
after adjustment for 8-oxoG. The association 
between U-As at GW30 and placental leptin 
decreased slightly but remained significant 
after adjustment for 8-oxoG. The associa-
tion between U-As at GW30 and IL-1β also 
decreased and was no longer significant after 
adjusting for 8-oxoG. Coefficients for the 
association of U-As at GW30 with placental 
IFNγ and TNFα were decreased markedly 
after adjustment for 8-oxoG (in addition to 
age, SES, and TC), but estimates for asso-
ciations of 8-oxoG with placental IFNγ and 
TNFα remained positive and significant 
when adjusted for U-As at GW30.
In multivariable adjusted linear regres-
sion, placental expression of IL-6 and IL-10 
was significantly associated with the num-
ber of days of maternal urinary tract infec-
tion during pregnancy (β-coefficient = 0.45, 
p = 0.044) and acute respiratory infection 
(β-coefficient = 0.50, p = 0.017), respectively, 
after adjustment for U-As and other potential 
confounders. We observed no significant asso-
ciations between mothers’ other morbidities 
(fever and diarrhea) and other markers in the 
placenta and cord blood.
Maternal As exposure and cord blood 
cytokines. For all cytokines with the exception 
of IL-5, > 90% of the plasma samples were 
above the LOD of the multiplex cytokine 
assays (Bio-Plex) (data not shown). In the 
case of IL-5, 50% of the samples were below 
LOD. Cord blood proinflammatory cytokines 
TNFα, IL-8, IL-1β, and to some extent IFNγ 
showed U-shaped curves by quartiles of U-As 
at GW30 (Figure 2) but not at GW8 (data 
not shown). In ANOVA post hoc test (least 
significant difference) using quartiles of U-As 
at GW30, we observed a significant difference 
between second and the fourth quartiles for 
log-transformed IL-8 [means and 95% confi-
dence intervals (CIs) in the second and fourth 
quartiles were 4.51 (3.83–5.18) pg/mL and 
5.96 (5.30–6.61) pg/mL, respectively] and 
log-transformed TNFα [means (95% CIs) 
in the second and fourth quartiles were 1.20 
(0.77–1.63) pg/mL and 1.90 (1.44–2.34) 
pg/mL, respectively]. IL-1β also showed an 
increase at higher U-As levels; however, the 
difference was not significant (p = 0.09). In 
the ANCOVA analyses, after adjusting for 
age, SES, and TC, we observed significant 
differences only for IL-8 (p = 0.012) but not 
for TNFα. We observed no significant associ-
ations between maternal As exposure and the 
rest of the 14 cord blood cytokines evaluated 
(data not shown).
Discussion
The results of this study suggest that maternal 
exposure to As during pregnancy increases oxi-
dative stress and inflammation in the placenta. 
The measured placental proinflammatory 
cytokines (IL-1β, TNFα, and IFNγ) were 
mainly influenced by oxidative stress, part 
of which might have been mediated by As. 
To our knowledge, this is the first report of 
As-associated leptin expression in the placenta, 
apparently independent of oxidative stress. 
Maternal exposure in early pregnancy was also 
associated with decreased pan T cells (CD3+ 
cells) in the placenta but apparently not with 
other cell types studied. We also report pre-
liminary evidence that maternal As exposure 
showed a U-shaped association with proinflam-
matory cytokine concentrations in cord blood.
Reactive oxygen species produced by As 
are known to induce a wide range of lesions, 
including DNA lesions (Xu et al. 2008). We 
have previously reported As-related increase 
in 8-OHdG in urine in the MINIMat cohort 
(Engstrom et al. 2010). Earlier studies have 
assessed oxidative stress in tissues by immuno-
staining of 8-oxoG, a marker of nuclear 
DNA damage (Nakae et al. 2005). In this 
study, immunohistochemical localization of 
8-oxoG in the placenta, particularly in the 
cytotrophoblasts, syncytiotrophoblasts, and 
capillary endothelium, showed a strong associ-
ation with U-As. Oxidative stress is known to 
induce the release of proinflammatory factors, 
including cytokines, in the placenta that act 
in autocrine, paracrine, and juxtracrine man-
ners for diverse functions (Cindrova-Davies 
et al. 2007). Our models showed that the sig-
nificant relationships between maternal U-As 
and placental proinflammatory cytokines 
were no longer significant after adjustment for 
8-oxoG, suggesting that the cytokine produc-
tion was mainly influenced by oxidative stress, 
only part of which appeared to be mediated 
by As. However, both As and oxidative stress 
seemed to play an important role in placental 
proinflammatory IL-1β production.
Table 3. Multivariable adjusted analysis of associations of maternal U-As (µg/L in early and late pregnancy) and placental 8-oxoG (ACIA score) with placental 
effect markers (ACIA score).
Independent variable
Unadjusted Adjusteda Adjusteda
Dependent variable U-As at GW8 U-As at GW30 8-oxoG U-As at GW8 8-oxoG U-As at GW30 8-oxoG
Leptin
β-Coefficient 0.04 0.31 0.10 0.04 0.11 0.25 0.05
95% CI –0.09 to 0.17 0.18 to 0.43 0.03 to 0.17 –0.22 to 0.13 0.03 to 0.18 0.07 to 0.44 –0.03 to 0.13
p-Value 0.57 < 0.001 0.005 0.61 0.008 0.008 0.19
IL-1β
β-Coefficient 0.71 0.92 0.32 0.50 0.26 0.71 0.20
95% CI 0.21 to 1.20 0.43 to 1.41 0.06 to 0.59 –0.2 to 1.2 –0.05 to 0.57 –0.03 to 1.47 –0.11 to 0.52
p-Value 0.006 < 0.001 0.018 0.15 0.09 0.06 0.19
TNFα
β-Coefficient 0.78 0.53 0.36 0.52 0.29 0.15 0.35
95% CI 0.37 to 1.19 0.07 to 1.02 0.12 to 0.58 –0.08 to 1.12 0.02 to 0.56 –0.56 to 0.85 0.05 to 0.64
p-Value < 0.001 0.025 0.004 0.084 0,034 0.67 0.025
IFNγ
β-Coefficient 0.64 0.58 0.38 0.37 0.31 0.19 0.34
95% CI 0.21 to 1.06 0.11 to 1.04 0.15 to 0.60 –0.26 to 1.0 0.04 to 0.60 –0.52 to 0.90 0.04 to 0.64
p-Value 0.004 0.015 0.002 0.23 0.029 0.59 0.029
CI, confidence interval. Outcomes and exposure variables were natural log transformed. 
aAdjusted for mother age, SES, and TC.Arsenic-induced inflammation in placenta
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We observed U-shaped concentration–
response curves for cord blood proinflamma-
tory cytokines IL-8 and TNFα; however, we 
observed no relationship between maternal 
As exposure and anti-inflammatory or regu-
latory cytokines. Cord blood proinflamma-
tory cytokines IL-6 and IL-8 are used as a 
marker of early-onset infection in premature 
infants (Krueger et al. 2001). Some caution 
must be used when comparing the cytokines 
measured in cord blood with those measured 
in placenta, because different methods are 
used. There is a lack of studies of cord blood 
cytokine levels in healthy neonates (Lyon 
et al. 2009), so it is difficult to interpret the 
As-induced changes in cord blood cytokines 
in the present study.
Immune tolerance at the maternal–fetal 
interface is established with decreased cell-
mediated immunity and increased humoral 
immunity. A diverse array of both proinflam-
matory and anti-inflammatory cytokines are 
released by the trophoblasts with an overall 
shift toward anti-inflammatory mediators, 
thereby promoting maternal tolerance (Hunt 
et al. 2010). In the present study, high As 
exposure was associated with a shift toward 
proinflammatory cytokines (IL-1β, TNFα, 
IFNγ, and IL-8) in both placenta and cord 
blood. Proinflammatory cytokines (TNFα, 
IFNγ) were found to induce apoptosis of pla-
cental trophoblasts in vitro (Yui et al. 1994). 
In addition, we found that morbidity during 
pregnancy was associated with increased pla-
cental expression of IL-6 and IL-10, indicat-
ing that placental cytokine expression also 
changes in response to clinically relevant 
events. Maternal circulating proinflamma-
tory cytokines (IL-1β, TNFα) induced by 
infection or inflammation have previously 
been associated with preeclampsia (Rinehart 
et al. 1999). Elevated levels of cord blood 
proinflammatory cytokines (IL-1β, TNFα, 
and IL-6) have also been associated with pre-
term birth, one of the most common causes 
of neonatal morbidity and mortality (Lyon 
et al. 2009), as well as chorioamnionitis, 
brain white matter damage, and chronic lung 
disease in preterm infants (An et al. 2004; 
Kaukola et al. 2006).
In vitro As exposure at higher   levels induces 
apoptosis in immune cells (de la Fuente et al. 
2002). In vitro and in vivo investigations 
showed significant inverse correlation between 
chronic As exposure and the number and func-
tion of T-regulatory cells in adults chronically 
exposed to As (Hernandez-Castro et al. 2009). 
We report that maternal As exposure was asso-
ciated with a decrease in the number of pan 
T cells in the placenta in a dose-dependent 
manner in the presence of elevated levels of 
inflammatory cytokines (Table 2, Figure 1A). 
In particular, the CD4+CD25+ regulatory T 
cells (Treg cells) and regulatory natural killer 
cells play important roles in the maintenance 
of immune tolerance in the maternal–fetal 
interface. During preeclampsia, Treg cells are 
down-regulated in the placenta compared 
with normal pregnancy (Sasaki et al. 2007). 
It is possible that apoptotic deletion of CD4+ 
Treg cells among the total CD3+ cells (given 
no significant changes in the CD8+ cell num-
bers) leads to an imbalance in the placental 
immune tolerance. One limitation of this 
study is that we did not measure CD4+ cells in 
placenta. We noted no significant association 
between CD3 or other immune cell mark-
ers and 8-oxoG expression, suggesting that 
the suppressive effect of As on T-lymphocyte 
numbers is probably mediated by pathways 
other than oxidative stress.
As exposure in late gestation was sig-
nificantly associated with increased placen-
tal leptin expression, starting at fairly low As 
exposure levels (consumption of < 50 µg/L 
in drinking water). Leptin is tightly regulated 
and involved in key processes in fetal develop-
ment, including transfer of nutrients from 
placenta to the developing fetus (Jansson 
et al. 2003; White et al. 2006). Placental lep-
tin production is increased during hypoxia 
(Spranger et al. 2008) and in various obstetri-
cal conditions such as diabetes, preeclampsia, 
and intrauterine growth retardation (Iwagaki 
et al. 2004; Mise et al. 1998). Further stud-
ies are necessary to understand the potential 
health effects of As-induced leptin expression 
in the placenta.
Conclusion
As exposure during pregnancy was associated 
with oxidative stress and increased inflam-
matory cytokines and leptin in the placenta. 
Furthermore, As exposure in early pregnancy 
was associated with reduced T-cell numbers in 
the placenta, indicating a disruption of immune 
balance. It is possible that such changes may 
influence fetal programming and increase sus-
ceptibility to infectious diseases postnatally 
(Jansson and Powell 2007). Indeed, we have 
observed an As-associated increase in infant 
morbidity in infectious diseases (Rahman et al. 
2010; Raqib et al. 2009). Therefore, effects of 
prenatal As exposure on immune function may 
also have consequences for susceptibility to 
various diseases later in life.
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